31/01/2026
Change begins here.
This year, the UK National Screening Committee will review its stance on group B Strep screening after the results of the GBS3 Trial are published (expected in the Spring).
We are very hopeful the results of the trial will provide robust evidence that GBS-specific testing is more effective in protecting newborns than the current risk-based approach, leading to national policy change.
Be the first to receive updates: https://gbss.org.uk/email-newsletter/